Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025
Rhea-AI Summary
Venus Concept (NASDAQ: VERO), a global medical aesthetic technology leader, has scheduled its third quarter fiscal year 2025 financial results release for November 13, 2025, before market opening.
The company will host a conference call at 8:00 a.m. Eastern Time on the same day, featuring a management discussion and Q&A session. Participants can join via phone using access code 13756285 or watch the live webcast on the company's investor relations website. A two-week replay will be available for those unable to attend.
Positive
- None.
Negative
- None.
News Market Reaction 7 Alerts
On the day this news was published, VERO gained 5.65%, reflecting a notable positive market reaction. Argus tracked a peak move of +20.7% during that session. Argus tracked a trough of -2.2% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $258K to the company's valuation, bringing the market cap to $5M at that time. Trading volume was exceptionally heavy at 18.4x the daily average, suggesting very strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2025 financial results will be released before the market opens on Thursday, November 13, 2025.
Management will host a conference call at 8:00 a.m. Eastern Time on November 13, 2025 to discuss the results of the quarter and host a question and answer session. Those who would like to participate may dial 877-407-2991 (+1 201-389-0925 for international callers) and provide access code 13756285. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.
For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853 (201-612-7415 for international callers); access code 13756285. The webcast will be archived at ir.venusconcept.com.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, Masters Special Situations, and Madryn Asset Management, L.P.
Investor Relations Contact: ICR Healthcare on behalf of Venus Concept Mike Piccinino, CFA VenusConceptIR@ICRHealthcare.com
FAQ
When will Venus Concept (VERO) release Q3 2025 earnings?
How can investors join Venus Concept's Q3 2025 earnings call?
What time is Venus Concept's Q3 2025 earnings call?
How long will Venus Concept's Q3 2025 earnings call replay be available?
